Ferroptosis regulates hemolysis in stored murine and human red blood cells
- PMID: 39541586
- PMCID: PMC11863713
- DOI: 10.1182/blood.2024026109
Ferroptosis regulates hemolysis in stored murine and human red blood cells
Abstract
Red blood cell (RBC) metabolism regulates hemolysis during aging in vivo and in the blood bank. However, the genetic underpinnings of RBC metabolic heterogeneity and extravascular hemolysis at population scale are incompletely understood. On the basis of the breeding of 8 founder strains with extreme genetic diversity, the Jackson Laboratory diversity outbred population can capture the impact of genetic heterogeneity in like manner to population-based studies. RBCs from 350 outbred mice, either fresh or stored for 7 days, were tested for posttransfusion recovery, as well as metabolomics and lipidomics analyses. Metabolite and lipid quantitative trait loci (QTL) mapped >400 gene-metabolite associations, which we collated into an online interactive portal. Relevant to RBC storage, we identified a QTL hotspot on chromosome 1, mapping on the region coding for the ferrireductase 6-transmembrane epithelial antigen of the prostate 3 (Steap3), a transcriptional target to p53. Steap3 regulated posttransfusion recovery, contributing to a ferroptosis-like process of lipid peroxidation, as validated via genetic manipulation in mice. Translational validation of murine findings in humans, STEAP3 polymorphisms were associated with RBC iron content, lipid peroxidation, and in vitro hemolysis in 13 091 blood donors from the Recipient Epidemiology and Donor Evaluation Study. QTL analyses in humans identified a network of gene products (fatty acid desaturases 1 and 2, epoxide hydrolase 2, lysophosphatidylcholine acetyl-transferase 3, solute carrier family 22 member 16, glucose 6-phosphate dehydrogenase, very long chain fatty acid elongase, and phospholipase A2 group VI) associated with altered levels of oxylipins. These polymorphisms were prevalent in donors of African descent and were linked to allele frequency of hemolysis-linked polymorphisms for Steap3 or p53. These genetic variants were also associated with lower hemoglobin increments in thousands of single-unit transfusion recipients from the vein-to-vein database.
© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Conflict of interest statement
Conflict-of-interest disclosure: A.D., K.C.H., and T.N. are founders of Omix Technologies Inc. A.D., S.L.S., and T.N. are scientific advisory board (SAB) members for Hemanext Inc. A.D. is a SAB member for Macopharma Inc. S.L.S. is a SAB member for Alcor, Inc, and consultant for Tioma, Inc, and Team Conveyer Intellectual Properties, serves as executive director for Worldwide Initiative for Rh Disease Eradication and as CEO for Ferrous Wheel Consultants, LLC. J.C.Z. is a founder of Svalinn Therapeutics. B.R.S. is an inventor on patents and patent applications involving ferroptosis; cofounded and serves as a consultant to ProJenX, Inc, and Exarta Therapeutics; holds equity in Sonata Therapeutics; and serves as a consultant to Weatherwax Biotechnologies Corporation and Akin Gump Strauss Hauer & Feld LLP. The remaining authors declare no competing financial interests.
Update of
-
Ferroptosis regulates hemolysis in stored murine and human red blood cells.bioRxiv [Preprint]. 2024 Jun 11:2024.06.11.598512. doi: 10.1101/2024.06.11.598512. bioRxiv. 2024. Update in: Blood. 2025 Feb 13;145(7):765-783. doi: 10.1182/blood.2024026109. PMID: 38915523 Free PMC article. Updated. Preprint.
Comment in
-
QTLs unlock RBC storage hemolysis secrets.Blood. 2025 Feb 13;145(7):661-662. doi: 10.1182/blood.2024027136. Blood. 2025. PMID: 39946153 No abstract available.
References
-
- Bianconi E, Piovesan A, Facchin F, et al. An estimation of the number of cells in the human body. Ann Hum Biol. 2013;40(6):463–471. - PubMed
MeSH terms
Substances
Grants and funding
- R01 HL146442/HL/NHLBI NIH HHS/United States
- R01 HL161004/HL/NHLBI NIH HHS/United States
- R35 CA209896/CA/NCI NIH HHS/United States
- HHSN268201100008C/HL/NHLBI NIH HHS/United States
- HHSN268201100007C/HL/NHLBI NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- R01 HL148151/HL/NHLBI NIH HHS/United States
- HHSN268201100001C/WH/WHI NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- HHSN268201100009I/HL/NHLBI NIH HHS/United States
- HHSN268201100005G/HL/NHLBI NIH HHS/United States
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- HHSN268201100008I/HL/NHLBI NIH HHS/United States
- 75N92019D00033/HL/NHLBI NIH HHS/United States
- HHSN268201100006C/HL/NHLBI NIH HHS/United States
- HHSN268201100005I/HL/NHLBI NIH HHS/United States
- R01 HL126130/HL/NHLBI NIH HHS/United States
- HHSN268201100009C/HL/NHLBI NIH HHS/United States
- R21 HL150032/HL/NHLBI NIH HHS/United States
- HHSN268201100005C/HL/NHLBI NIH HHS/United States
- R01 HL149714/HL/NHLBI NIH HHS/United States
- HHSN268201100007I/HL/NHLBI NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- R01 GM067945/GM/NIGMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous